VAM
TECX

Vazirani Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Vazirani Asset Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,500
Closed -$192K – 29
2024
Q1 		$192K Sell
12,500
-41,667
-77% -$660K 0.53% 15
2023
Q4 		$884K Buy
54,167
+15,144
+39% +$260K 3.63% 7
2023
Q3 		$721K Buy
+39,023
New +$690K 1.1% 14

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vazirani Asset Management's TECX Position: Q2 2024 in Review

Vazirani Asset Management sold out of Tectonic Therapeutic (TECX) in Q2 2024, closing a stake of 12,500 shares — an estimated $192K sold.

Vazirani Asset Management first reported a position in TECX in Q3 2023 and held it in 3 quarters. The position peaked at $884K in Q4 2023. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2024.

  • Vazirani Asset Management reported no remaining Tectonic Therapeutic position as of Q2 2024 after selling out during the quarter.
  • Vazirani Asset Management sold 12,500 Tectonic Therapeutic shares in Q2 2024, an estimated $192K.
  • Vazirani Asset Management first reported a position in Tectonic Therapeutic in Q3 2023 and held it in 3 quarters.
  • Vazirani Asset Management's Tectonic Therapeutic position peaked at $884K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2024.

Based on Vazirani Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.